Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.180
+0.030 (0.95%)
At close: Aug 6, 2026, 4:00 PM EDT
3.180
0.00 (0.00%)
Pre-market: Aug 7, 2026, 7:35 AM EDT

Myriad Genetics Revenue

Myriad Genetics had revenue of $190.70M in the quarter ending June 30, 2026, a decrease of -10.51%. This brings the company's revenue in the last twelve months to $806.60M, down -3.16% year-over-year. In the year 2025, Myriad Genetics had annual revenue of $824.50M, down -1.56%.

Revenue (ttm)
$806.60M
Revenue Growth
-3.16%
P/S Ratio
0.38
Revenue / Employee
$298,741
Employees
2,700
Market Cap
304.17M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025824.50M-13.10M-1.56%
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.50M23.96%
Dec 31, 2020557.10M-81.50M-12.76%
Jun 30, 2020638.60M-212.50M-24.97%
Jun 30, 2019851.10M107.40M14.44%
Jun 30, 2018743.70M15.00M2.06%
Jun 30, 2017728.70M-11.80M-1.59%
Jun 30, 2016740.50M17.40M2.41%
Jun 30, 2015723.10M-55.10M-7.08%
Jun 30, 2014778.20M165.00M26.91%
Jun 30, 2013613.20M117.20M23.63%
Jun 30, 2012496.01M93.92M23.36%
Jun 30, 2011402.08M39.44M10.87%
Jun 30, 2010362.65M36.12M11.06%
Jun 30, 2009326.53M103.67M46.52%
Jun 30, 2008222.86M77.57M53.39%
Jun 30, 2007145.29M31.01M27.13%
Jun 30, 2006114.28M31.87M38.68%
Jun 30, 200582.41M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
NeoGenomics766.30M
OPKO Health587.90M
GeneDx Holdings454.43M
Castle Biosciences357.28M
Fulgent Genetics323.93M
Biodesix102.94M
Burning Rock Biotech74.58M
Exagen71.12M
Revenue Rankings